Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hwail Pharm Co Ltd

+ Add to Watchlist

061250:KS

6,320 KRW 70 1.12%

As of 01:23:41 ET on 03/05/2015.

Snapshot for Hwail Pharm Co Ltd (061250)

Open: 6,250 Day's Range: 6,230 - 6,370 Volume: 76,639
Previous Close: 6,250 52wk Range: 5,390 - 7,810 1-Yr Rtn: -3.61%

Stock Chart for 061250

No chart data available.
  • 061250:KS 6,320
  • 1D
  • 1M
  • 1Y
6,250
Interactive 061250 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 061250

Current P/E Ratio (ttm) 20.2564
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.6760
Earnings Per Share (ttm) 312.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 91,077.25
Shares Outstanding (M) 14.41
30 Day Average Volume 92,260
Price/Book (mrq) 0.9902
Price/Sale (ttm) 0.9060
Dividend Indicated Gross Yield 1.58%
Cash Dividend (KRW) 100.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 061250

No data available

Company Profile & Key Executives for 061250

Hwail Pharm Co., Ltd. produces pharmaceutical raw materials. The Company's products include Talniflumate, Alibendol, and Oxatomide. Hwail supplies these materials to companies dealing with finished pharmaceutical products.

Lee Joung-KyuChairman/Co-Rep DirectorCho Joong-MyungChairman/Co-Rep Director
Park Pil-JunPresident/Co-Rep DirectorKo Jae-KyuPresident
More Company Profile & Key Executives for 061250

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil